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Proteinase K forms a 1:l stable complex with its naturally occurring protein inhibitor, PK13. The crystal structure of this complex has been 
determined by a combination of molecular eplacement and single isomorphous replacement methods. The model comprises all of the 459 residues: 
279 for proteinase K and 180 for PK13, and it was retined to an R-factor of 19.2% at a resolution of 2.5 A. Association of these two molecules in 
the complex indicates the binding of PK13 in the substrate recognition site of the enzyme. The active serine residue of proteinase K in this complex 
possesses a somewhat different configuration to that found in its native structure and hence renders the enzyme inactive. 
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1. Introduction 
Proteinase K is a serine protease isolated from the 
fungus Tritirachium album Limber [l]. It consists of 279 
amino acid residues with a molecular weight of 28,790 
Da [2]. It can readily hydrolyze native proteins and re- 
mains active in the presence of urea and sodium dodecyl 
sulfate [3,4]. These properties make proteinase K a useful 
tool for the preparation of protein-free samples of DNA 
or RNA [5-71. According to its amino acid sequence [2] 
and three-dimensional structure [8,9], proteinase K, 
which is of eukaryotic origin, is similar to bacterial sub- 
tilisins. It displays no significant specificity towards pro- 
tein substrates but its cleavage pattern on oxidized insu- 
lin B-chain suggests that the smallest peptide hydrolyza- 
ble by proteinase K should be a tetrapeptide [lo]. This 
was further supported by recent results of X-ray analyses 
of proteinase K complexed with synthetic substrate ana- 
logues, which showed that the incoming substrate forms 
an antiparallel B-pleated sheet structure in the substrate 
recognition site of the enzyme [ 11,121. 
PK13 is a natural inhibitor of proteinase K with which 
it forms a 1: 1 complex with a dissociation constant of 
lo-’ M at pH 7.8 [13]. PK13 is isolated from wheat and 
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consists of 180 amino acids with a molecular weight of 
19,641 Da [14]. It is a bifunctional inhibitor: it can inhibit 
serine proteases of the subtilisin family as well as a- 
amylases from wheat and several other cereals [13,15]. 
Furthermore, it was shown that the inhibitory activity of 
this inhibitor against a-amylase can be retained even in 
the presence of subtilisin, which leads to the conclusion 
that this inhibitor may be ‘double- headed’ containing 
separate sites directed against a-amylases and subtilisins 
[W. 
In view of the tight association between protease and 
inhibitor and of the importance, both theoretical and 
practical, of controlling the activity of proteases, we un- 
dertook a crystallographic study of the complex between 
proteinase K and its inhibitor PK13. In this paper we 
present he structural results that explain the association 
of the two molecules and the molecular details of the 
inhibition. 
2. Experimental 
2.1. Purt$cation, crystallization and crystal properties 
Proteinase K was purchased from E. Merck, Darmstadt, and was 
purified further according to [16]. PKD was isolated from wheat as 
described earlier [13]. A complex between proteinase K and PK13 was 
prepared by mixing them in equimolar amounts. The mixture was 
purified by Sephadex G-75 gel filtration to remove any unreacted en- 
zyme or inhibitor. Crystals of the complex were grown at room temper- 
ature from 25% ammonium sulfate in 50 mM Tris-HCl, pH 7.8. Large 
single crystals of an average size of 0.2 x 0.4 x 1.5 mm3 were obtained 
by vapor diffusion. They diffracted X-rays to 2.5 A resolution. The 
crystals belong to the orthorhombic space group P2,2,2, with cell di- 
mensions a = 64.07 A, b = 66.84 A and c = 133.82 A. 
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2.2. Data collection and processing 
Diffraction data of the native and one heavy atom derivative crystals 
were collected in house with SiemensZNicolet X-1OOA area detector on 
an Elliott GX18 rotating anode with monochromatixed CuKa radia- 
tion. Crystals were mounted as C* along the spindle axis and oscillated 
for 0.25’ per frame. Data processing was performed using the program 
XDS 1171. The results are summarized in Table 1. For heaw atom 
deriva& preparation, asingle crystal was soaked at room temperature 
for 2 days in 1 mM solution of HgCl, in 50 mM Tris-HCl at pH 7.8 
containing 25% saturated ammonium sulfate. 
2.3. Structure determination 
The structure of the proteinase K- PK13 complex was solved by a 
combination of molecular eplacement (MR) and single isomorphous 
replacement (SIR) methods. In order to solve the structure of the 
enzyme part, ret&d coordinates of proteinase K at 1.5 A resolution 
were used as a search model [9,18] and the MR was carried out using 
the program package MERLOT [ 191. In both the rotation and trausla- 
tion searches, ingle solutions were obtained using the native X-ray data 
between 8.0 and 4.5 A resolution with Z 2 3q. This unique solution was 
then optimized by an R-factor minimization and was confirmed 
through an intermolecular contact search as implemented in the MER- 
LOT program package. 
In a similar way, an attempt was also made to determine the structure 
of the inhibitor part of the complex using PK13 coordinates determined 
at 2.5 A resolution [20]. However, this was unsuccessful, probably due 
to the fact that PK13 constitutes only 40% of the complex. On the other 
hand, MR phases alone could not generate an interpretable lectron 
density map in which the inhibitor model could be built. 
Thus to obtain the structure of the inhibitor part, SIR was carried 
out using the Hg derivative of the complex crystals. All the calculations 
were performed with the CCP4 program package. In a difference Pat- 
terson map only a single heavy atom binding site was interpretable, 
which was confirmed by calculating a difference Fourier map using the 
MR phases. Table 2 summarizes the heavy atom parameters. Based on 
this single site, phases were calculated and the resulting SIR phases were 
then combined with the MR phases using the program SIGMAA as 
implemented in the CCW program package. An overall fi e 
of 0.66 was obtained for reflections between 5.0 and 2.71 Y 
of merit 
resolution. 
Electron density maps were calculated using the combined phases as 
well as MR phases with the coefficients 2F,-F, and F,-F,, and based on 
these maps the inhibitor chain was traced on an Evans and Sutherland 
picture system using the program FRODO [21]. 
2.4. Model building and refinement 
An electron density map generated with the combined phases led to 
some minor corrections for the enzyme part; however, the inhibitor 
model had to be built in a series of steps. At first it was possible to fit 
as many as 131 out of 180 amino acid residues of the inhibitor, PK13, 
and the initial R-factor of 37.4% with the enzyme only dropped to 
31.3% at this stage. In each of the subsequent steps, after manualfitting 
the model was refined for a few cvcles with the moaram PROLSO 1221 
considering the data between 5.0 and 3.0 A resdlut&. However, mapi 
were generated with all the reflections (Z 2 3~3 using the model biased 
phases. In the final step the model consisting of the complete enzyme 
and 164 residues of the inhibitor gave an R-factor of 22.8% with the 
data where Z 2 3a,. It was then submitted for further refinement with 
the uroaram XPLOR 1231 adding more reflections uu to 2.5 A resolu- 
tion-and Z 2 2q. After t<o cycle; of positional refinement followed by 
one cycle of simulated annealing, it was possible to fit all the residues 
in the electron density map and the refinement was continued thereafter 
followed by individual temperature factor refinement. Fig. 1 illustrates 
a typical section of the final map. 
The current model, which comprises all the 459 residues (279 for 
proteinase K and 180 for PK13) but without solvent molecules, gives 
an R-factor of 19.2% (considering the reflections between 5.0 and 2.5 
A resolution and with I B 2s.J after assigning individual temperature 
factors for all non-hydrogen atoms. Refinement of the individual 
B-factors was carried out using an XPLOR protocol [24]. B-factors 
obtained for main chain atoms lie within the range 6.3 to 30.0 A2 with 
a mean of 14.1 A’, and for side chain atoms between 6.5 and 31.1 AZ 
with a mean of 14.7 A2. However, a few non-glycine residues, mostly 
of the inhibitor and in the external oops only, were found outside the 
energetically favoured regions in a Ramachandran Plot [25]. In the 
present model root-mean-square deviations in bond length and in bond 
angle are 0.018 A and 3.82’, respectively. 
3. Results and discussions 
Fig. 2 shows the association of proteinase K and PK13 
in the crystal structure of their complex. Proteinase K 
resembles a hemisphere with a crevice on the flat surface 
where the active center is located. PK13 is more like a 
cone in its shape and the conical tip is inserted into the 
crevice of the enzyme, binds there through non-covalent 
interaction and forms a stable complex. 
Though a few corrections involving only side chains 
were necessary, the folding of the enzyme molecule in the 
complex is essentially the same as that of native pro- 
teinase K [9]. However, major conformational changes 
are observed in the inhibitor part if it is compared with 
the corresponding structure of PK13, determined inde- 
pendently [20]. When these two independently deter- 
mined structures of proteinase K and PKI3 were super- 
imposed with the corresponding structures in the com- 
plex using the common a-carbon atoms, the root-mean- 
square deviations in the aligned positions were 0.3 8, and 
3.75 A for proteinase K and PK13, respectively. Further- 
more, the mean value of the individual temperature fac- 
tors of all non-hydrogen atoms of this complex is calcu- 
lated as 14.4 AZ. The value for proteinase K alone is 11.9 
8’ whereas for PK13 alone it is 18.2 A’. These results 
suggest that the inhibitor is more flexible; alternatively 
it may be claimed that the difference in the values is due 
to the more accurate determination of the enzyme part 
of the complex. Similar results were also obtained for 
subtilisin-eglin crystal structures [26,27]. 
A closer view of the assembly of these two molecules 
in the complex, involving the active center of the enzyme 
and its binding with the inhibitor, is shown in Fig. 3. The 
inhibitor peptide involving residues Ala-85 to Thr-88 
(the numbers l-l 80 are used for the 180 residues of PK13 
and 181-459 for proteinase K) forms a three- stranded 
antiparallel/?-pleated sheet with the two parallel strands, 
Gly-280 to Tyr-284 and Leu-313 to Gly-316, of pro- 
teinase K and they are held together by a strong hydro- 
gen-bonding network. For a proper orientation of this 
part of the inhibitor a significant rearrangement oc- 
curred in the substrate recognition pocket of the enzyme. 
In particular the position of the Tyr-284 side chain now 
stacks together with the side chain of Tyr-86 (of PK13) 
with a rotation of about 90” to each other, contributing 
to their tight binding in the complex. Distance calcula- 
tions show that the inhibitor in this active center region 
is further stabilized through many other intermolecular 
as well as intramolecular hydrogen bonding, involving 
both the main chain and side chain atoms. 
The catalytic triad is grossly the same but NE2 of 
His-249 is 3.92 A from OG of Sex--404. This would mean 
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Fig. 1. A section of the 6nal 2F,,-F, electron density map showing the fit of the residues Asp-16 to Tyr-20 of the inhibitor PKI3. 
Fig. 2. Association of PK13 (green) and proteinase K (white) in the crystal structure of their complex. 
Fig. 3. A stereo-view of the binding of PK13 (green) to proteinase K. The catalytic center and substrate recognition pocket of the enzyme as found 
in the complex (white) are superpositioned onthe relevant part of the native enzyme structure (brown). Water 335 of the native structure is labelled. 
that the histidine cannot take the proton of the serine, a 
step necessary for the proteolytic activity of the enzyme 
through nucleophilic attack by the deprotonated serine. 
The NE2 of His-249 is now hydrogen-bonded with the 
Thr-88 carbonyl oxygen of the inhibitor and stabilizes it 
further. The OG of Ser-404 turns almost 90” to a posi- 
tion where it is now hydrogen bonded with the side chain 
of Asn-341 and this position is equivalent to the 
‘oxyanion hole’ in the native structure of the enzyme 
where a water molecule was located [9]. In the native 
structure, this water molecule, which was considered to 
be involved in the deacylation process of the enzyme- 
170 
Table 1 
Data collection summary for native and heavy atom derivative crystals 
Native HgCl, 
Resolution (A> 2.5 2.8” 
Total observations 57,576 39,996 
Unique reflections 19,462 14,516 
Completeness (%) 93 89 
R,c,ge (%)b 5.92 5.6 
“16.7% of the possible data are also observed in the 2.5-2.8 A resolu- 
tion. 
bBInerge = rz I(< 1, h 
> - z#z Z,) x 100 
h 
where c I,, > is the mean of the Zh observations of reflection h. 
substrate complex, was hydrogen bonded with the side 
chain of Asn-341. Although the present structure has 
not yet been fully analyzed with respect to solvent, no 
electron density was observed in this position in the dif- 
ference map, which would correspond to a water mole- 
cule. The change in position of Ser-404 was not observed 
in the structures of the enzyme with substrate analogues 
[11,12] and with hexapeptide inhibitor [28]. 
In a previous paper [20], cleavage of PK13 by pro- 
teinase K has been reported. However, that occurs at or 
near pH 6.0. Under the experimental conditions of our 
biochemical investigation, i.e. at pH 7.8 we did not ob- 
serve any such cleavage. Moreover, in this present crys- 
tallographic study we can see the whole molecule of 
PK13 in the assembly of the complex and there is no sign 
of cleavage. The lack of cleavage is further supported by 
the fact that the distance from the oxygen of the active 
serine to the carbon of the putative scissile bond between 
Thr-88 and Cys-89 is 4.62 A. However, the correspond- 
ing distance in the complex of proteinase K with its 
hexapeptide inhibitor where cleavage does occur is 2.11 
A [28]. 
In summary our result shows that, upon binding to the 
enzyme, the inhibitor is placed on the active site and 
pushes the oxygen of the active serine to form a hydrogen 
bond with Asn-341 where it can not be the part of the 
active catalytic triad. 
Addition of solvent and further refinement are now in 
progress. 
Table 2 
Re6ned heavy-atom-parameters of the HgCl, derivative 
Fractional coordinates, x 0.1061 
Y 0.0108 
z 0.0648 
Relative occupancy 3.15 
Temperature factor 31.8 
Cullis R-factor 0.511 
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